Impact of New Genomic Technologies on Understanding Adverse Drug Reactions

por Maggo, Simran D. S., Savage, Ruth L., Kennedy, Martin A.
Publicado 2015

Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions

por Maggo, Simran D. S., Savage, Ruth L., Kennedy, Martin A.
Publicado 2016

The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand

por Maggo, Simran D.S., Sycamore, Kyra L.V., Miller, Allison L., Kennedy, Martin A.
Publicado 2019

Pharmacogenetics of Statin-Induced Myotoxicity

por Kee, Ping Siu, Chin, Paul Ken Leong, Kennedy, Martin A., Maggo, Simran D. S.
Publicado 2020

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

por Kee, Ping Siu, Maggo, Simran D. S., Kennedy, Martin A., Chin, Paul K. L.
Publicado 2023

Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus

por Kee, Ping Siu, Maggo, Simran D. S., Kennedy, Martin A., Barclay, Murray L., Miller, Allison L., Lehnert, Klaus, Curtis, Maurice A., Faull, Richard L. M., Parker, Remai, Chin, Paul K. L.
Publicado 2022

Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples

por Hitchman, Leonie M., Faatoese, Allamanda, Merriman, Tony R., Miller, Allison L., Liau, Yusmiati, Graham, Oscar E. E., Kee, Ping Siu, Pearson, John F., Fakahau, Tony, Cameron, Vicky A., Kennedy, Martin A., Maggo, Simran D. S.
Publicado 2022